(a) Have successfully completed 80 hours of
classroom and laboratory training, applicable to parenteral administrations,
for which a written directive is required, of any beta emitter, or any
photon-emitting radionuclide with a photon energy less than 150 keV, and/or
parenteral administration of any other radionuclide for which a written
directive is required. The training must include the following:
1. Radiation physics and
instrumentation;
2. Radiation
protection;
3. Mathematics
pertaining to the use and measurement of radioactivity;
4. Chemistry of radioactive material for
medical use; and
5. Radiation
biology; and
(b) Have
work experience, under the supervision of an authorized user who meets the
requirements in Rule
64E-5.657,
64E-5.660
or
64E-5.663, F.A.C., NRC or equivalent Agreement State requirements, in the
parenteral administration, for which a written directive is required, of any
beta emitter, or any photon-emitting radionuclide with a photon energy less
than 150 keV, and/or parenteral administration of any other radionuclide for
which a written directive is required. A supervising authorized user who meets
the requirements in Rule
64E-5.660,
F.A.C., NRC or equivalent Agreement State requirements, must have experience in
administering dosages as specified in sub-sub-subparagraph
64E-5.660(2)(a)
2.g.(III) or
64E-5.660(2)(a)
2.g.(IV), F.A.C., NRC or equivalent Agreement State requirements. The work
experience must involve the following:
1.
Ordering, receiving, and unpacking radioactive materials safely, and performing
the related radiation surveys;
2.
Performing quality control procedures on instruments used to determine the
activity of dosages, and performing checks for proper operation of survey
meters;
3. Calculating, measuring,
and safely preparing patient or human research subject dosages;
4. Using administrative controls to prevent a
medical event involving the use of unsealed radioactive material;
5. Using procedures to contain spilled
radioactive material safely, and using proper decontamination procedures;
and
6. Administering dosages to
patients or human research subjects, that include at least 3 cases involving
the parenteral administration, for which a written directive is required, of
any beta emitter, or any photon-emitting radionuclide with a photon energy less
than 150 keV and/or at least 3 cases involving the parenteral administration of
any other radionuclide, for which a written directive is required;
and
(c) Have obtained
written attestation that the individual has satisfactorily completed the
requirements in subsection 64E-5.663(2) or 64E-5.663(3), F.A.C., of this
section, and have demonstrated the ability to function independently as an
authorized user to fulfill the radiation safety related duties for a medical
use licensee authorized for the parenteral administration of unsealed
radioactive material requiring a written directive. Have obtained written
attestation, signed by a preceptor authorized user or a residency program
director who represents a consensus of residency program faculties (as long as
at least one member of the residency program faculty is an authorized
individual in the same category designated by the applicant seeking authorized
status) who meets the requirements in Rule
64E-5.657,
64E-5.660
or
64E-5.663, F.A.C., NRC or equivalent Agreement State requirements. A
preceptor authorized user, who meets the requirements in Rule
64E-5.660,
F.A.C., must have experience in administering dosages as specified in
sub-sub-subparagraph
64E-5.660(2)(a)
2.g.(III) or
64E-5.660(2)(a)
2.g.(IV), F.A.C.